Testing an AI tool for carb counting in type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests an AI-powered tool (called Tiabete) that helps you count carbohydrates more easily. If you have type 1 diabetes and use insulin, the tool may help you manage your blood sugar better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 1 diabetes.
- You are 6 to 18 years old (with a caregiver) or an adult over 18.
- Your most recent A1C result is between 7.2% and 10.5%.
- You use a basal-bolus insulin routine (a long-acting plus a fast-acting insulin).
- You agree to use the study's AI tool through WhatsApp at least 3 days a week and attend clinic visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a structured educational program delivered through a mobile app can help teens with type 1 diabetes improve their blood sugar control (HbA1c), feel more confident managing their condition, and take better care of themselves.
This trial tests an AI-powered app that teaches parents how to count carbohydrates better for their child with type 1 diabetes. If you already manage your child's carb counting and insulin doses, this study may help make it easier and more accurate.
This study tests if talking with a motivational interviewer and using WhatsApp to check in can help teenagers with type 1 diabetes improve their blood sugar control and feel more confident managing their condition. You would attend clinic visits and get support through your phone.
This study tests an artificial intelligence-powered mobile app to help you manage your diabetes. You'll use the app to track your health and get personalized suggestions.
This study tests if an artificial intelligence tool can predict how type 2 diabetes changes over time in youth. It involves wearing a continuous glucose monitor for 6 weeks and may help doctors personalize care.
This study tests an artificial intelligence tool that uses ECG (a heart tracing) to spot likely blood sugar changes in people with type 1 diabetes. It may help improve earlier detection of “glycaemic events” without invasive testing.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.